Search research articles
Contact Us
Filters
Showing results (851-860 of 1,166) with videos related to
Page
of 117
Sort By:
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
March 8, 2012
Eosinophilic infiltration of the esophagus following endoscopic ablation of Barrett's neoplasia
K D Halsey, M Arora, W J Bulsiewicz, et al.
Human Molecular Genetics
|
November 13, 2010
Alström Syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity
Daniel Jagger, Gayle Collin, John Kelly, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine
|
June 18, 2009
Limited utility of name-based tuberculosis contact investigations among persons using illicit drugs: results of an outbreak investigation
Rana Jawad Asghar, David E Patlan, Mark C Miner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 1999
Clinical case definitions for Argentine hemorrhagic fever
L H Harrison, N A Halsey, K T McKee, et al.
The Journal of Infectious Diseases
|
July 1, 1992
Tuberculin skin test reactivity among adults infected with human immunodeficiency virus
M P Johnson, J S Coberly, H C Clermont, et al.
Neuropharmacology
|
July 1, 1991
The effects of the competitive NMDA receptor antagonist CPP on the high pressure neurological syndrome in a primate model
P C Pearce, M J Halsey, C J MacLean, et al.
Plos One
|
November 21, 2014
Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples
Subhamoy Pal, Allison L Dauner, Indrani Mitra, et al.
Reviews of Infectious Diseases
|
May 1, 1989
Field evaluation of a simplified unit-dose syringe for administration of measles vaccine
N A Halsey, S Berry, P Carrasco, et al.
Investigational New Drugs
|
September 1, 2005
A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer
Ranjana Advani, Bert L Lum, George A Fisher, et al.
Cancer
|
January 13, 2004
A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma
Ranjana Advani, Prema Peethambaram, Bert L Lum, et al.
Page
of 117
Search research articles
Search
Showing results (851-860 of 1,166) with videos related to
Sort By:
Page
of 117
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
March 8, 2012
Eosinophilic infiltration of the esophagus following endoscopic ablation of Barrett's neoplasia
K D Halsey, M Arora, W J Bulsiewicz, et al.
Human Molecular Genetics
|
November 13, 2010
Alström Syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity
Daniel Jagger, Gayle Collin, John Kelly, et al.
Journal of Urban Health : Bulletin of the New York Academy of Medicine
|
June 18, 2009
Limited utility of name-based tuberculosis contact investigations among persons using illicit drugs: results of an outbreak investigation
Rana Jawad Asghar, David E Patlan, Mark C Miner, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 19, 1999
Clinical case definitions for Argentine hemorrhagic fever
L H Harrison, N A Halsey, K T McKee, et al.
The Journal of Infectious Diseases
|
July 1, 1992
Tuberculin skin test reactivity among adults infected with human immunodeficiency virus
M P Johnson, J S Coberly, H C Clermont, et al.
Neuropharmacology
|
July 1, 1991
The effects of the competitive NMDA receptor antagonist CPP on the high pressure neurological syndrome in a primate model
P C Pearce, M J Halsey, C J MacLean, et al.
Plos One
|
November 21, 2014
Evaluation of dengue NS1 antigen rapid tests and ELISA kits using clinical samples
Subhamoy Pal, Allison L Dauner, Indrani Mitra, et al.
Reviews of Infectious Diseases
|
May 1, 1989
Field evaluation of a simplified unit-dose syringe for administration of measles vaccine
N A Halsey, S Berry, P Carrasco, et al.
Investigational New Drugs
|
September 1, 2005
A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer
Ranjana Advani, Bert L Lum, George A Fisher, et al.
Cancer
|
January 13, 2004
A Phase II trial of aprinocarsen, an antisense oligonucleotide inhibitor of protein kinase C alpha, administered as a 21-day infusion to patients with advanced ovarian carcinoma
Ranjana Advani, Prema Peethambaram, Bert L Lum, et al.
Page
of 117